Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis.
about
Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the futureContribution of vitamin D insufficiency to the pathogenesis of multiple sclerosisThe risk of smoking on multiple sclerosis: a meta-analysis based on 20,626 cases from case-control and cohort studiesB cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms.Environmental factors in multiple sclerosis.Breastfeeding, previous Epstein-Barr virus infection, Enterovirus 71 infection, and rural residence are associated with the severity of hand, foot, and mouth disease.
P2860
Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis.
@ast
Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis.
@en
type
label
Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis.
@ast
Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis.
@en
prefLabel
Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis.
@ast
Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis.
@en
P2093
P2860
P356
P1476
Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis.
@en
P2093
Andrew J Morgan
Eilis J O'Reilly
Kassandra L Munger
Kelly Claire Simon
Susan Finerty
P2860
P304
P356
10.1177/1352458511433920
P577
2012-01-30T00:00:00Z